CNEW VanEck China New Economy ETF
- 6.460
- -0.030-0.46%
The quarterly adjustment of the MSCI Index excludes 15 Hong Kong stocks. The effective date is scheduled for early June
① Which individual stocks will MSCI China adjust quarterly? ② How much impact does the MSCI Index have on the market?
April 2024 Production and Sales Data Report
In April, these listed companies were “broken through the threshold”! Drone concept stocks were surveyed by a group of institutions. A list of individual stocks with the highest number of visits received by the agency
① Sort through the list of listed companies that received more than 400 institutional visits in April (with photos). Lanqi Technology, Huaming Equipment, and Tianfu Communications ranked in the top three; ② Huazuan Testing and Hikvision, which are under the same drone concept, are all “famous on the list”.
Sweeping robot “Shuang Xiong” financial report perspective: Whose inflection point? Who's growing?
① Whether it's a sweeper robot or a floor washer, increasing penetration rate is a core logic that has been mentioned over and over again by all parties. Essentially, the focus of clean appliance investors is still on growth; ② The biggest difference between Covos and Stone Technology's annual financial reports is growth; ③ The reporter also learned from a leading clean appliance manufacturer that they are actively planning to go overseas, and the number of employees in relevant departments has increased dramatically in recent years.
Science and Technology Innovation Board Evening News|Stone Technology's Q1 net profit increased 95.23% year-on-year, China Electronics Research and Development plans to invest 1.35 billion yuan to build the Yangtze River Delta headquarters
① Guodian Quantum Q1 has a net loss of 41.4736 million yuan; ② Maolai Optics: plans to repurchase the company's shares of 25 million yuan to 50 million yuan; ③ Xin'an Century: Net loss of 297.66 million yuan in the first quarter; ④ Haohan Depth: Lianchuang Yongqin plans to reduce its holdings by no more than 1%; ⑤ Yingjixin: plans to invest in the construction of the “Yingjixin R&D and Operation Headquarters Project” in the Zhuhai High-tech Zone.
Smart grid concept performance fulfills Haixing Electric Power's net profit of nearly 1 billion dollars and exceeds expectations | Annual Report Interpretation
① Haixing Electric Power's net profit in 2023 exceeded institutional expectations; ② The company plans to “pay 11 yuan for 10 shares”, and the dividend strength reached a record high; ③ overseas markets are blooming more, and the domestic market is relatively lackluster.
The Ministry of Industry and Information Technology has further increased the supply of high-performance intelligent computing optical modules, which is still the most deterministic sector in AI construction
① Vice Minister of Industry and Information Technology Shan Zhongde said at a press conference on April 11 that the supply of high-performance intelligent computing will be increased and intelligent computing centers will be built at computing power hubs. ② Southwest Securities believes that optical modules are the most beneficial and deterministic sector for AI. Demand is expected to explode in '24 as big model manufacturers accelerate AI construction, and the intention to add orders is strong and the pace is frequent.
CICC: Maintaining Hisense Home Appliance (00921)'s “outperforming the industry” rating, the target price was raised to HK$35.2
CICC expects Hisense Home Appliances (00921) to steadily improve its profitability and operating efficiency in the future.
Returning to a high-growth trajectory, net profit increased by more than 70% Stone Technology: Replicating Experience to More Emerging Regional Markets|Annual Report Interpretation
① Judging from historical performance, the net profit growth rate of Stone Technology's revenue all hit the highest level in three years. Among them, the net profit growth rate escaped single-digit growth in 2021 and negative growth in 2022. ② A reporter from the Financial Services Association discovered that the gross margin gap between the company's domestic and foreign markets has widened further. The company said it was mainly the increase in the launch of new products. The new products performed well in overseas markets, contributing to the increase in gross margin.
“Clearance” dividends? Marketing-driven performance problem unsolved Baiya Co., Ltd. plans to split 99% of the year's net profit|Annual Report Interpretation
① Net profit returned to growth in 2023, and Baiya shares vigorously paid dividends; ② The company plans to distribute a cash dividend of 236 million yuan, which will almost completely split the net profit for the whole year; ③ Despite the increase in performance, the company's profitability index did not rise but fell due to the surge in marketing costs.
Up to 82.27%, 6 companies over 50%. Next week, a large percentage of companies will be unbanned.
① The top three unbanned market capitalization were: Autoway ($8.111 billion), Bank of Xi'an ($3,695 billion), and Feilo Audio ($3.386 billion); ② Judging from the unbanned ratio, Wangli Security, Bide Technology, and Liande Co., Ltd. ranked in the top three, with percentages as high as 82.27%, 67.47%, and 65.66%, respectively. In addition, Fengshang Culture, Boshuo Technology, and Guanzhong Ecology have also lifted more than 50% of the ban.
Downstream capital expenditure is “in full swing” and the boom in the tire mold industry is expected to continue
① In recent years, leading companies in the tire industry, which have increased both revenue and profits, have begun a new wave of capital expenditure. Upstream tire mold-related companies have sufficient orders, and the industry boom is expected to continue. ② An industry insider told the Financial Federation reporter that Chinese tire mold companies are not hesitant to invest in R&D, the technical level of their products is constantly improving, and they have won many orders.
Nvidia continues its history, and the new high-light module leader is expected to continue to be catalysed
① Nvidia's US stock once rose to 5%, continuing to reach a record high, with a total market capitalization of 1.71 trillion US dollars. The company received price increases from Goldman Sachs and Bank of America to 800 US dollars. ② Tech giants such as Nvidia, Intel, TSMC, and Broadcom are scrambling to deploy silicon photonic technology in fields such as optical interconnection, and breakthroughs are imminent.
Overseas markets help Stone Technology expects 2023 net profit to be the highest in history
① Since Q2 of 2023, Stone Technology's net profit scale in a single quarter has continuously broken through the highest in history, and net profit to the mother in 2023 also reached the highest value since 2019; ② Regarding the reason for the change in performance, Stone Technology said that 2023 benefited from rapid growth in overseas consumer demand and achieved relatively rapid growth in overseas revenue.
Keeping up with Sailun and Morikirin General Co., Ltd. launched the second phase of the Cambodian project to speed up overseas production capacity construction for domestic tire companies
① The tire industry is booming in 2023. Leading domestic tire industry companies will expand capital expenditure and accelerate overseas production capacity layout. ② Industry insiders said that by increasing overseas production capacity, domestic tire companies are rapidly increasing their global market share and have initially taken on an “international model”.
Next week, the ban on market capitalization exceeding 70 billion dollars will be lifted, 9 companies will account for more than 50%, and the EVA leader will have a monopoly of nearly 20 billion
① A total of 9 stocks were lifted, accounting for more than 50% of the total share capital; ② The lifting of the ban peaked on Friday, with a total market value of 29.433 billion yuan, including Lianhong Xinke, Youfa Group, Boqian New Materials, and Crystal Special Equipment.
The pharmaceutical industry, which is the cornerstone of Alice's marketing advantages, grants exclusive promotion rights for RET inhibitors in mainland China
① Cornerstone Pharmaceutical announced that it has granted Alice the exclusive commercial promotion rights for the RET inhibitor “platinib capsule” (Pugetinib) in mainland China; ② Before Alice obtained the right to promote platinib domestically, Cinda Biotech's RET inhibitor “ceptinib” (Ruituo) was officially commercialized domestically in March of this year.
The performance of the sweeper robot duo is “two heavens of ice and fire”: Covos, a 17-fold bull stock, was “double killed by Davis,” and Shitou Technology experienced “huge” shareholders' holdings to cash out. Can speeding up overseas create a second gro
① Covos's Q3 net profit fell by more than 90% year-on-year, with the biggest cumulative drop in stock prices of 57% since February's high. Shitou Technology's Q3 recorded a record high in net profit in a single quarter. Since the January low, the cumulative increase in stock prices has been 91%. Is “sweeping the floor” about to be relocated? ② The overall sales volume of the robot sweeper industry has declined year after year, and domestic players are trying to find a second growth curve by deploying other products such as floor scrubbers. Can speeding up overseas open up room for growth?
The stock price bucked the trend and rose! Alice's core product was certified as a breakthrough treatment by the FDA, and domestic competitor products are in simultaneous clinical trials
① Alice's core product, vometinib mesylate tablets, for “first-line treatment of EGFR exon 20 insertion mutation NSCLC (non-small cell lung cancer)” has been recognized as a breakthrough treatment by the FDA; ② A product on the same competitive track as vometinib — domestic clinical trials of shuvetinib-related indications from Deezer Pharmaceuticals (688192.SH) have also begun.
Just ten days! Agreements for various innovative drugs to go overseas have been finalized one after another. How much potential is left on the circuit?
Analysts pointed out that innovating the export regulation market is an important breakthrough for the Chinese pharmaceutical industry in seeking market growth, reducing internal competition that simply relies on the domestic primary market and enhancing the value space for innovation.